Peptide pharmaceuticals for treatment of NASH and other disorders
US11541028B2 · kind B2 · utility
3Cited by
22References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 3, 2019 |
| Grant date | Jan 3, 2023 |
| Priority date | — |
| Expiry date | Jul 21, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/549
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides peptide products comprising a peptide covalently attached to a surfactant moiety which have improved properties, including increased duration of action and bioavailability. The peptide products are useful for treating insulin resistance, diabetes, obesity, metabolic syndrome and cardiovascular diseases, and conditions associated therewith, such as NASH and PCOS.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.